Full Committee Hearing: Prostate Cancer: New Questions About Screening and Treatment
On Thursday, March 4, 2010, the House Committee on Oversight and Government Reform held a hearing titled: "Prostate Cancer: New Questions About Screening and Treatment." Recent debates about the efficacy of screening for prostate cancer have sparked new concerns about both screening and treatment for the disease. In addition to focusing on prostate screening and treatment controversy, and current research efforts, representatives from the National Cancer Institute and the U.S. Army Medical Research and Material Command discussed their respective prostate cancer research programs.
Witnesses
Panel I
Mr. Louis Gosset, Jr.
Award winning actor and prostate cancer victim
Ms. Betty Gallo
Co-Founder, Women Against Prostate Cancer
Widow of Rep. Dean A. Gallo
Mr. Thomas Farrington|
President and Founder
Prostate Health Education Network, Inc.
Mr. Theodore L. DeWeese, M.D.
Professor of Urology, Professor of Oncology
Chairman, Radiation Oncologist-in-Chief
Sidney, Kimmel Comprehensive Cancer Center
Johns Hopkins University
Panel II
Mr. Otis W. Brawley, M.D.
Chief Medical Officer
American Cancer Society
Mr. James L. Mohler, M.D.,
Associate Director and Senior Vice President for Translation Research
Chair, Department of Urologic Oncology
Department of Urology at the Roswell Park Cancer Institute
Dr. Steven G. Kaminsky, Ph.D.
Vice President for Research and Director of Research Administration
Uniformed Services University of Health Sciences Center for Prostate Disease Research
Ms. Faina Shtern, M.D.
President and Chief Executive Officer
AdMeTech Foundation
Panel III
Mr. William L. Dahut, M.D.
Senior Investigator
National Cancer Institute, Medical Oncology Branch and Affiliates
Ms. Carolyn J.M. Best, Ph.D.
Program Manager, Prostate Cancer Research Center
Department of Defense, U.S. Army Medical Research and Material Command, Congressionally Directed Medical Research Programs